{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:29Z","timestamp":1795008569000,"version":"4.9.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Emerging evidence supports a bidirectional gut\u2013pancreas axis in which microbial dysbiosis, barrier dysfunction, and altered metabolite fluxes contribute to pancreatogenic diabetes (T3cDM). Whether gut microbial changes reflect systemic metabolic disturbances or primarily arise from exocrine pancreatic insufficiency (EPI) remains unclear. We profiled the gut microbiome of 48 outpatients with T3cDM, type 1 diabetes (T1DM), and healthy controls. Genus-level 16S rRNA data were analyzed using cross-validated LASSO logistic regression and patient-specific community metabolic models. T3cDM showed reduced \u03b1-diversity and distinct \u03b2-diversity compared with T1DM and controls. Key compositional shifts included enrichment of\n                    <jats:italic>Enterobacteriaceae<\/jats:italic>\n                    (notably\n                    <jats:italic>Escherichia\u2013Shigella<\/jats:italic>\n                    ) and\n                    <jats:italic>Streptococcaceae<\/jats:italic>\n                    in T3cDM. LASSO models discriminated T3cDM from T1DM (AUC 0.867; accuracy 0.818), highlighting\n                    <jats:italic>Blautia, Escherichia\u2013Shigella, Streptococcus, Clostridium, and Faecalibacterium<\/jats:italic>\n                    as predictors. Metabolic modelling indicated elevated\n                    <jats:italic>Escherichia\u2013Shigella<\/jats:italic>\n                    growth in T3cDM and disease-specific metabolite fluxes. Gut microbial shifts in T3cDM predominantly reflect EPI rather than systemic metabolic disturbances characteristic of T1DM, underscoring the central role of exocrine pancreatic dysfunction in shaping the gut microbiome and its metabolic activity.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1786756","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:19:44Z","timestamp":1774588784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiency"],"prefix":"10.3389","volume":"17","author":[{"given":"Erika Kvalem","family":"Soto","sequence":"first","affiliation":[{"name":"Biocenter, Institute of Bioinformatics, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Engl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]},{"name":"Department of Medicine, Hospital of Brixen (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University","place":["Bessanone-Brixen, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mederer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Cibulkova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Piater","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dunzendorfer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Waschina","sequence":"additional","affiliation":[{"name":"Institute for Human Nutrition and Food Science, Division Nutriinformatics, Christian-Albrechts-University of Kiel","place":["Kiel, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kaser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Aden","sequence":"additional","affiliation":[{"name":"Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein","place":["Kiel, Germany"]},{"name":"Department of Internal Medicine I., Christian-Albrechts-University and University Hospital Schleswig-Holstein","place":["Kiel, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Trajanoski","sequence":"additional","affiliation":[{"name":"Biocenter, Institute of Bioinformatics, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejim.2012.12.017","article-title":"Diabetes mellitus secondary to pancreatic diseases (Type 3c)","volume":"13","author":"Ewald","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i11.112204","article-title":"Pancreatogenic diabetes: Pathophysiology, diagnosis, and management challenges","volume":"17","author":"Wang","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-s256","article-title":"Primary Prevention of Cardiovascular Disease in People With Dysglycemia. Diabetes Care","volume":"31","author":"Bianchi","year":"2008"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf623","article-title":"Approach to the Patient With Pancreatogenic Diabetes","volume":"111","author":"Ode","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107214","article-title":"A systematic review of the relationship between gut microbiota and prevalence of pancreatic diseases","volume":"199","author":"Jankowski","year":"2025","journal-title":"Microb Pathog"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245920","article-title":"Microbiota in Pancreatic Diseases: A Review of the Literature","volume":"10","author":"Schepis","year":"2021","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-082018-124306","article-title":"Pancreas\u2013microbiota cross talk in health and disease","volume":"39","author":"Adolph","year":"2019"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00189.2006","article-title":"Taste receptors in the gastrointestinal tract. II. L-amino acid sensing by calcium-sensing receptors: implications for GI physiology","volume":"291","author":"Conigrave","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5625\/lar.2018.34.4.140","article-title":"Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis","volume":"34","author":"Kim","year":"2018","journal-title":"Lab Anim Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02098-3","article-title":"Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status","volume":"10","author":"Hu","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0341087","article-title":"Shifts in amino acids profile in chronic pancreatitis","volume":"21","author":"Malvik","year":"2026","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA02186H","article-title":"Exploring metabolic biomarkers and regulation pathways of acute pancreatitis using ultra-performance liquid chromatography combined with a mass spectrometry-based metabolomics strategy","volume":"9","author":"Guo","year":"2019","journal-title":"RSC Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15100666","article-title":"Advancing Clinical and Pathophysiological Insights into Pancreatitis Using Lipidomics and Metabolomics","volume":"15","author":"Ahmed","year":"2025","journal-title":"Metabolites"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2260","article-title":"Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)","volume":"28","author":"Ewald","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071398","article-title":"Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies","volume":"12","author":"Marroncini","year":"2024","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620944720","article-title":"The microbiome in pancreatic diseases: Recent advances and future perspectives","volume":"8","author":"Ammer-Herrmenau","year":"2020","journal-title":"UEG J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000329188","article-title":"Pancreatogenic diabetes: special considerations for management","volume":"11","author":"Cui","year":"2011","journal-title":"Pancreatology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1477","article-title":"Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer","volume":"66","author":"Andersen","year":"2017","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00606-19","article-title":"MICOM: metagenome-scale modeling to infer metabolic interactions in the gut microbiota","volume":"5","author":"Riener","year":"2020"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3703","article-title":"Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota","volume":"35","author":"Magn\u00fasd\u00f3ttir","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.045","article-title":"The gut microbiome in pancreatic disease","volume":"17","author":"Akshintala","year":"2019"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/biomedicines11030667","article-title":"The cause and effect relationship of diabetes after acute pancreatitis","volume":"11","author":"S\u0301liwin\u0301ska-Mosson\u0301","year":"2023"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43640","DOI":"10.1038\/srep43640","article-title":"Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities","volume":"7","author":"Jandhyala","year":"2017"},{"key":"B33","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1038\/s41598-021-90024-w","article-title":"The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes","volume":"11","author":"Talukdar","year":"2021"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.3390\/cancers15215140","article-title":"Pancreatic exocrine insufficiency and the gut microbiome in pancreatic cancer: a target for future diagnostic tests and therapies","volume":"15","author":"Halle-Smith","year":"2023"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset Type 1 diabetes","volume":"13","author":"Yuan","year":"2022"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of intestinal barrier function by microbial metabolites","volume":"11","author":"Ghosh","year":"2021"},{"key":"B37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12934-020-01482-2","article-title":"Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency","volume":"19","author":"Ritz","year":"2020"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.047","article-title":"Impaired Exocrine Pancreatic Function Associates With Changes in Intestinal Microbiota Composition and Diversity","volume":"156","author":"Frost","year":"2019","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000232","article-title":"The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens","volume":"11","author":"Frost","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","article-title":"The gut microbial metabolite formate exacerbates colorectal cancer progression","volume":"4","author":"Ternes","year":"2022"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: a fundamental role in health and disease","volume":"5","author":"Vancamelbeke","year":"2017"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013"},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk in humans","volume":"368","author":"Tang","year":"2013"},{"key":"B45","doi-asserted-by":"publisher","first-page":"634511","DOI":"10.3389\/fmicb.2021.634511","article-title":"Applications of machine learning in human microbiome studies: feature selection, biomarker identification, disease prediction and treatment","volume":"12","author":"Marcos-Zambrano","year":"2021"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00434-20","article-title":"A framework for effective application of machine learning to microbiome-based classification problems","volume":"11","author":"Topc\u0327uog\u0306lu","year":"2020"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1204590","DOI":"10.3389\/fmicb.2023.1257002","article-title":"Advancing microbiome research with machine learning: key findings from the ML4Microbiome COST Action","volume":"14","author":"D\u2019Elia","year":"2023"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1786756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:19:45Z","timestamp":1774588785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1786756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":47,"alternative-id":["10.3389\/fendo.2026.1786756"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1786756","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2026.1786756.s001","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1786756"}}